Lakshman Segar

634 total citations
19 papers, 520 citations indexed

About

Lakshman Segar is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Lakshman Segar has authored 19 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Lakshman Segar's work include Metabolism, Diabetes, and Cancer (9 papers), Diabetes Treatment and Management (7 papers) and Pancreatic function and diabetes (6 papers). Lakshman Segar is often cited by papers focused on Metabolism, Diabetes, and Cancer (9 papers), Diabetes Treatment and Management (7 papers) and Pancreatic function and diabetes (6 papers). Lakshman Segar collaborates with scholars based in United States, Egypt and Australia. Lakshman Segar's co-authors include John Y. Jun, Noha M. Shawky, Islam Osman, Prahalathan Pichavaram, Zhexi Ma, Maha Abdalla, Payaningal R. Somanath, Ninu Poulose, Anna Goc and Mark Kozak and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Pharmacology and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Lakshman Segar

19 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lakshman Segar United States 13 283 100 100 95 78 19 520
Li‐Hao Huang United States 13 229 0.8× 138 1.4× 117 1.2× 175 1.8× 110 1.4× 18 676
Srividya Velagapudi Switzerland 9 171 0.6× 56 0.6× 68 0.7× 111 1.2× 95 1.2× 12 423
Priya Raman United States 16 309 1.1× 85 0.8× 43 0.4× 100 1.1× 58 0.7× 21 603
Akira Takaguri Japan 13 217 0.8× 65 0.7× 79 0.8× 119 1.3× 37 0.5× 34 500
Melroy Miranda Switzerland 7 243 0.9× 75 0.8× 122 1.2× 113 1.2× 52 0.7× 10 586
Gloria Torres Chile 10 406 1.4× 186 1.9× 68 0.7× 71 0.7× 63 0.8× 11 664
Minxiang Lei China 14 303 1.1× 124 1.2× 117 1.2× 89 0.9× 65 0.8× 28 610
Ju-Qiong Wang China 8 244 0.9× 103 1.0× 60 0.6× 149 1.6× 53 0.7× 8 513
Francesca Ferrelli Italy 7 320 1.1× 63 0.6× 100 1.0× 90 0.9× 180 2.3× 8 664
Shujian Wei China 11 183 0.6× 85 0.8× 49 0.5× 52 0.5× 62 0.8× 22 488

Countries citing papers authored by Lakshman Segar

Since Specialization
Citations

This map shows the geographic impact of Lakshman Segar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakshman Segar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakshman Segar more than expected).

Fields of papers citing papers by Lakshman Segar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lakshman Segar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakshman Segar. The network helps show where Lakshman Segar may publish in the future.

Co-authorship network of co-authors of Lakshman Segar

This figure shows the co-authorship network connecting the top 25 collaborators of Lakshman Segar. A scholar is included among the top collaborators of Lakshman Segar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakshman Segar. Lakshman Segar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Segar, Lakshman, et al.. (2022). AICAR promotes endothelium-independent vasorelaxation by activating AMP-activated protein kinase via increased ZMP and decreased ATP/ADP ratio in aortic smooth muscle. Journal of Basic and Clinical Physiology and Pharmacology. 33(6). 759–768. 3 indexed citations
2.
Pichavaram, Prahalathan, et al.. (2020). Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice. European Journal of Pharmacology. 890. 173666–173666. 8 indexed citations
3.
Segar, Lakshman, et al.. (2019). SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes. European Journal of Pharmacology. 846. 23–29. 44 indexed citations
4.
Shawky, Noha M. & Lakshman Segar. (2018). Sulforaphane improves leptin responsiveness in high-fat high-sucrose diet-fed obese mice. European Journal of Pharmacology. 835. 108–114. 14 indexed citations
5.
6.
7.
8.
9.
Osman, Islam, Ninu Poulose, Vadivel Ganapathy, & Lakshman Segar. (2016). High fructose-mediated attenuation of insulin receptor signaling does not affect PDGF-induced proliferative signaling in vascular smooth muscle cells. European Journal of Pharmacology. 791. 703–710. 4 indexed citations
10.
Shawky, Noha M., Prahalathan Pichavaram, George S.G. Shehatou, et al.. (2016). Sulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese mice. The Journal of Nutritional Biochemistry. 32. 73–84. 37 indexed citations
11.
12.
13.
Ahmed, Heba A., et al.. (2015). Vascular Protection with Dipeptidyl Peptidase‐ IV inhibitors in Diabetes: Experimental and Clinical Therapeutics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 35(3). 277–297. 4 indexed citations
14.
15.
Poulose, Ninu, et al.. (2013). Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells. American Journal of Physiology-Cell Physiology. 304(6). C574–C589. 55 indexed citations
16.
Abdalla, Maha, Anna Goc, Lakshman Segar, & Payaningal R. Somanath. (2013). Akt1 Mediates α-Smooth Muscle Actin Expression and Myofibroblast Differentiation via Myocardin and Serum Response Factor. Journal of Biological Chemistry. 288(46). 33483–33493. 58 indexed citations
17.
18.
Zhao, Yan, Swarajit Kumar Biswas, Patrick H. McNulty, et al.. (2011). PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates. American Journal of Physiology-Cell Physiology. 300(6). C1375–C1385. 43 indexed citations
19.
Jun, John Y., Zhexi Ma, & Lakshman Segar. (2011). Spontaneously diabetic Ins2+/Akita:apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis. American Journal of Physiology-Endocrinology and Metabolism. 301(1). E145–E154. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Hao Huang Breakdown of academic impact, for papers by Srividya Velagapudi Breakdown of academic impact, for papers by Priya Raman Breakdown of academic impact, for papers by Akira Takaguri Breakdown of academic impact, for papers by Melroy Miranda Breakdown of academic impact, for papers by Gloria Torres Breakdown of academic impact, for papers by Minxiang Lei Breakdown of academic impact, for papers by Ju-Qiong Wang Breakdown of academic impact, for papers by Francesca Ferrelli Breakdown of academic impact, for papers by Shujian Wei
Rankless by CCL
2026